Communicated by Charles G. Sibley, November 30, 1992 ABSTRACT Elevated blood levels of apolipoprotein(a), the component of lipoprotein(a) that distinguishes it from low density lipoprotein, are a major risk factor for atherosclerosis. The apolipoprotein(a) gene is highly similar to the pasminogen gene and to at least four other genes or pseudogenes. The 5' untranslated and flanking sequences of these six genes contain
extensive regions of near identity and share sequence elements involved in the initiation of transcription and translation. About 1000 base pairs of flanking DNA of each gene are sufficient to promote transcription in cultured hepatocytes. The apolipoprotein(a) gene promoter contains functional interleukin 6-responsive elements, consistent with the reported acute-phase response of apolipoprotein(a). Flanking genomic fragments ofthe apoliprotein(a) gene from two individuals with vastly different plasma apolipoprotein(a) concentrations have sequence differences that are reflected in differences in the rate of in vitro transcription.
Over the past decade, high plasma levels of lipoprotein(a) [Lp(a) ] have been established as one of the major risk factors for atherosclerosis and its major manifestations: myocardial infarction, restenosis following angioplasty and bypass surgery, and stroke (for reviews, see refs. 1-3). Two independent studies conclude that 27% of premature myocardial infarctions in males may be due to elevated Lp(a) (4, 5) . Unlike other lipoproteins, individual variation in Lp(a) concentration is almost entirely due to inheritance (6) . Lp(a) resembles low density lipoprotein (LDL) in its content of cholesterol, phospholipids, and apolipoprotein B-100. It is distinguished from LDL by the large glycoprotein apolipoprotein(a) [apo(a)] that is attached to the particle by disulfide linkage to apolipoprotein B-100. Cloning and sequencing of the cDNA of human apo(a) revealed an unexpected homology to plasminogen (7) . The 5' regions of the two cDNAs have nearly 100% identity, whereas other domains of the plasminogen and apo(a) have between 75% and 94% local sequence identity. An unusual feature of the apo(a) cDNA is the large number of times that one domain is repeated. This domain is homologous to kringle four of plasminogen and is variously repeated from about 15 to 40 times in individual apo(a) genes, resulting in a large number of molecular weight isoforms of the protein (7) (8) (9) . It is likely that the apo(a) gene arose from a duplication of the plasminogen gene, perhaps recently during mammalian evolution, with regions at the 5' end undergoing subsequent gene conversion.
Plasma Lp(a) concentration varies widely in the human population, ranging from <0.1 to >200 mg/dl. Since blood levels of Lp(a) are a major contributor to morbidity, it is important to understand its regulation. Metabolic and genetic evidence shows that Lp(a) synthesis, rather than catabolism, is the key determinant for plasma concentration (10, 11) and that it is the apo(a) component of the lipoprotein particle that is the most important determinant of its final concentration (1, 6, 8) . Studies in human populations show a general inverse relationship between the size ofthe apo(a) protein and plasma concentration (cf. refs. 1, 12, and 13). Protein translation or particle assembly might in some way account for this relationship. However, even within a given apo(a) isoform size class, a great deal of variation in plasma concentration exists, emphasizing the importance ofdistinct regulatory elements in the gene. This is supported by studies in humans and cynomolgous monkeys which show that hepatic apo(a) mRNA levels are related to Lp(a) concentration (14) (15) (16) . To begin to understand the control of apo(a) gene expression, we present here the sequence of the flanking regions of the apo(a) gene and closely related homologues and demonstrate the activity of these regions in transcription assays.t
MATERIALS AND METHODS
Cloning of 5' Flanking Region of the Apo(a) Gene and Related Members of the Plasminogen Gene Family. Electrophoresis, blot hybridization, and other standard molecular biology procedures essentially followed the protocols of Sambrook et al. (17) . Genomic libraries in bacteriophage A (A-ZAP II and Gigapack Gold II; Stratagene) were constructed from human genomic DNA digested to completion with EcoRI and screened with the probe pcr A (see below). In some cases, the EcoRI-digested DNA was size-selected by fractionation by 1% agarose gel electrophoresis. Positive clones were isolated as pBluescript plasmids by the in vivo excision procedures detailed by the manufacturer and sequenced to completion by the Sanger dideoxy method using a Sequenase kit (United States Biochemical) and oligonucleotide primers derived from either vector sequences or from previous sequence analysis of the cloned inserts. In some cases, nested deletion sets were produced by the exonuclease III mung bean system (Stratagene).
Oligonucleotide Primer Sequences. pcr 6, GCCTGTTG-GAAAGCTTG, and pcr 7, AGTAGAAGAACCACTTC, were used to generate the genomic DNA 483-bp probe designated pcr A. ACCACATGGCTTTGC, the reverse complement of sequence in the first kringle region of apo(a) mRNA, was used to determine the mRNA start site by reverse transcriptase extension. Human liver poly(A)+ RNA was isolated by the guanidium isothiocyanate procedure (18) .
Abbreviations: apo(a), apolipoprotein(a); LDL, low density lipoprotein; Lp(a), lipoprotein(a).
tThe sequences reported in this paper have been deposited in the GenBank data base [accession nos. L07899 for the human apo(a) gene exon 1, L07900 for apo(a)rg-B, and L07901 for apo(a)rg-C].
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Luciferase Reporter Gene Constructs. To assay promoter activity, we synthesized a series of reporter gene constructs (pLuc A-D), comprising the 5' flanking regions of the apo(a) gene and its homologues inserted into the polylinker region of pGeneLight-2 (Promega), a promoterless vector containing the firefly luciferase gene. The genomic inserts were isolated from modified pBluescript plasmids of the original clones from which genomic fragments 3' to the desired flanking regions had been removed by restriction enzyme digestion. The flanking region inserts were isolated from these modified plasmids by digestion with restriction enzymes appropriate for directional ligation into the pGeneLight-2 polylinker. The inserts contained 1.4 kb of DNA upstream of a Bal I site located 12 nucleotides before the translation initiation ATG for the Al, A2, and B fragments, 1.07 kb upstream of this site in the D fragments, and 3.0 kb upstream of a HincHI site at -54 for the C fragment.
Transfection and Assay of Reporter Gene Constructs. Plasmids for transfection were purified by two cesium chloride density gradient ultracentrifugations or by Qiagen (Studio City, CA) columns. For transient transfections with luciferase construct plasmids, HepG2 cells were seeded at 0.75 x 106 cells per 6-cm dish and maintained in Dulbecco's modified Eagle's medium (DMEM) (GIBCO/BRL) supplemented with 10% fetal calf serum. Transfections were performed when the cells attained 40-60% confluence. For each dish, 10 ,g of test plasmid DNA and 5 ,ug of pSV-j3-galactosidase control plasmid (Promega) were mixed with 1.5 ml of Opti-Mem medium (GIBCO/BRL) in a polystyrene tube, and 1.5 ml of Opti-Mem containing 30 ,ug of Lipofectin (GIBCO/BRL) was added. Complexes were allowed to form for 30 min at room temperature and the lipofectin/DNA mix was added to the dishes after washing the monolayers three times in Pucks saline A (GIBCO/BRL). After 16 hr the medium was replaced by 5 ml of DMEM containing 10% fetal calf serum, and incubation was continued for 48 hr before assay of cellular luciferase and ,B-galactosidase activity.
Monolayers were washed five times with ice-cold phosphate-buffered saline (PBS), scraped into 1 ml of PBS, and pelleted by centrifugation at 4°C for 10 sec in a Microfuge. The phosphate buffer, pH 7.8/1 mM dithiothreitol and lysed by three freeze-thaw cycles with vigorous Vortex mixing between each cycle. Lysates were stored in aliquots at -70°C ifnot assayed immediately. Luciferase activity was measured by mixing 100 ,ul of luciferase substrate solution (Promega) with 20 jul of cell lysate and a 0-to 10-sec integral was read in a Monolight 2001 luminometer (Analytical Luminescence Laboratories, San Diego). ,B-Galactosidase activity was measured after dilution of the lysates 1:100 in potassium phosphate buffer. Diluted lysate (20 ,ul) Mapping of the transcription start site (arrow) of apo(a). An antisense primer complimentary to nucleotides 60-72 downstream of the ATG of human apo(a) cDNA (7) was annealed to 20 ,tg of human liver poly(A)+ RNA and extended with reverse transcriptase as described (23) . A DNA sequence ladder is included as a size marker.
ies and sequenced to completion. Sequence analysis confirmed the existence' of more than four extremely homologous fragments of the genome, since three variants of the 1.3-kb fragment were isolated from one individual (Fig. 1) . Comparing the sequence of the cloned genomic fragments to the published cDNA sequence of human apo(a) and plasminogen (7, 20, 21) , we found that all four fragments contain a region of >95% sequence identity that encompasses the translation initiation codon and first ex'on of these genes and contains the -1400 -1300 -1200 identical sequence CAG/GTA at the first splice donor site.
[The first exon of the human plasminogen and apo(a) genes ends at an identical location 49 nucleotides following the ATG and codes for the first 16 amino acids of the signal peptide sequence.] The 4798 bp of our A fragment sequence contain an exact match with the 400-bp sequence of apo(a) I given by Ichinose (22) , and but one mismatch (at -21 before the ATG) with the overlapping region of apo(a) mRNA reported by McLean et al. (7) and extended by sequencing a pcr product of mRNA to nucleotide -141. The assignment of the A fragment to the bonafide apo(a) gene is consistent with the recovery ofoverlapping A genomic clones that contain the A fragment sequence with clones encoding kringle regions of apo(a) (R.M.L., unpublished data). The transcription start site of apo(a) mRNA was determined by primer extension with reverse transcriptase (Fig. 2) . The major start site appears to occur at 141 bases before the translation start ATG. This is 20 bases further downstream than the transcription start site reported for human plasminogen mRNA by Malgaretti et al. (24) . [pcr analysis suggests that both plasminogen and apo(a) mRNAs have minor start sites further upstream.] The sequence of the 5' region of the human apo(a) gene is given in Fig. 3 (Fig. 4) , suggesting that more than just plasminogen and apo(a) genes might be transcribed from this gene family (see Discussion). Apo(a) gene A fragments were cloned and tested from two individuals. Al derived from an individual with relatively high plasma Lp(a) concentration (30 mg/ml), whereas A2 derived from an individual with Lp(a) below the level of detection by ELISA and by Northern blot hybridization. The only DNA differences in the two A fragments are a single base substitution 914 nucleotides before the ATG and nine, rather than eight, copies of the repeated sequence TTTTA at position -1373 (see Fig. 3 ; these two locations are not homologous to the D fragment sequence). When normalized to a value of 100% for the Dl fragment, the promoter activity of Al was 53%, whereas A2 was only 11%, which is consistent with the lower plasma apo(a) concentration in the A2 individual. In addition, fragment B had 57% relative promoter activity, fragment C had 38%, D2 had 149%, and D3 had 23%. (25, 26) . One branch ofthe family tree that contains only kringle and protease-like domains includes plasminogen, apo(a), and hepatocyte growth factor. Hepatocyte growth factor contains 38% amino acid identity to plasminogen, whereas plasminogen and apo(a) are much closer homologues. Comparison of human plasminogen and apo(a) cDNA suggested that the apo(a) gene arose from a duplicated plasminogen gene through deletion of the exons encoding the preactivation peptide and kringles one through three and the multiplication of exons corresponding to its kringle four (7) . The degree of sequence similarity and the virtual confinement of apo(a) to primates indicates the recent emergence of the apo(a) gene. One intriguing exception is the finding of an Lp(a)-like lipoprotein in the insectivore, the hedgehog (27) . This may be an example of convergent evolution.
DISCUSSION
Hybridization to human chromosomes in situ, and to blots of human-rodent somatic cell hybrids, demonstrated that the highly related homologues of apo(a) and plasminogen genes are closely linked in the region 6q27 (28) (29) (30) region and exon one of the human apo(a) gene are contained in the 4.8-kb EcoRI "A" fragment, which matches the reported sequences of the 400-bp apo(a)I genomic fragment (22) and (with one mismatch) apo(a) cDNA (7 sequence motifs were found that correspond to interleukin 6-responsive elements (35, 36) . This is consistent with the finding that apo(a) can respond to trauma as an acute-phase protein (37) and our finding that interleukin 6 leads to an -5-fold enhancement of reporter gene activity in the transfected HepG2 cells (unpublished data). Evaluation ofthe role ofthese sequence elements in the apo(a) gene requires in vitro mutagenesis and DNA binding protein studies. Other regions of the apo(a) gene also remain to be tested for the presence of control elements.
Two ofthe hallmarks ofapo(a) gene activity are the striking inter-individual variation in plasma concentration (roughly 1000-fold in the population), contrasted with its relative insensitivity to age, diet, and environmental influences in each given person. Hence we hypothesize that a significant cause of the variation in apo(a) concentration is inherited differences in cis-acting elements of transcriptional control, perhaps of the constitutive or liver-specific variety. Preliminary evidence supporting this may be seen in the different in vitro transcription activities we found between the apo(a) genomic fragments isolated from two individuals with high and low plasma levels of apo(a). We expect that other individual differences in the 5' flanking and other regions of the apo(a) gene will contribute to the inherited variation in apo(a) plasma levels. The isolation and identification of the 5' regions of the apo(a), plasminogen, and homologous genes provide the tools to begin to study the regulation of these genes, which play important roles in the normal and pathologic status of blood vessels.
